REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 72 filers reported holding REPARE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $430 | +211.6% | 40,000 | +174.0% | 0.00% | – |
| Q1 2023 | $138 | -37.6% | 14,600 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $221 | -99.9% | 14,600 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $177,000 | -11.1% | 14,600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $199,000 | -5.2% | 14,600 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $210,000 | -23.6% | 14,600 | +9.8% | 0.00% | 0.0% |
| Q4 2021 | $275,000 | -17.2% | 13,300 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $332,000 | -21.7% | 12,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $424,000 | +12.2% | 12,900 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $378,000 | -14.1% | 12,900 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $440,000 | – | 12,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
| CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
| MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
| BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
| Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
| Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
| HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
| Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
| Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |